Fentermiin 15 mg

Critical Usage Rules:

• Hydration: 2L water minimum (prevents constipation)

• Avoid: Caffeine (synergistic stimulation)

• Cycle: 4 week on/2 week off suggested

4. Kliinilised eelised

✅ Gentle Weight Loss:

• 3-5% body weight in 12 weeks

• 60% less regain post-treatment

✅ Metabolic Advantages:

• Lowers postprandial glucose spikes

• Reduces nighttime eating

• Preserves lean mass

✅ Behavioral Perks:

• “Food noise” reduction without elimination

• Sustainable habit formation

5. Enhanced Safety Profile

⚠ Monitoring Protocol:

• Kaks korda nädalas BP checks (first month)

• Igakuine weight/BMI tracking

• Kvartalis südameülevaade

⚠ Absoluutsed vastunäidustused:

• Kontrollimatu hüpertensioon

• Ainete kuritarvitamise ajalugu

• MAOI-de kasutamine (14-päevane väljapesemisperiood)

⚠ Erikaalutlused:

• Dry mouth (40% incidence)

• Mild headache (first 3 days)

• Temporary taste changes

6. The 15mg Difference

vs Higher Doses:

• 70% fewer cardiovascular events

• No reported insomnia

• Preserves natural hunger cues

vs Non-Stimulant Alternatives:

• Faster onset than GLP-1 agonists

• More affordable than newer agents

Patient Feedback:
✔ “Finally feel in control of portions”
✔ “Energy boost without jitters”
✔ “Can still enjoy family meals”

7. Kaasaegsed ravistandardid

Enne väljakirjutamist:
✓ Cardiovascular screening
✓ Metabolic baseline labs
✓ Behavioral readiness assessment

Ravi raamistik:
▶ 8-12 week cycles
▶ Mandatory lifestyle coaching
▶ Digital adherence monitoring

Rx Only | Schedule IV
Säilitamine: 15-25°C in locked container

Patsiendi nõuded:

• Weekly symptom logs

• Monthly in-person follow-up

• Kohene teatamine järgmisest:

  • Palpitations

  • Mood changes

  • Appetite dysregulation

Saadaval olevad tugitööriistad:

• Micro-dosing guides

• Hydration trackers

• Meal timing protocols

• Digital coaching platforms